escr

EU Bans Patents on Embryonic Stem Cells

By Wesley J. Smith, J.D., Special Consultant to the CBC Good. As anticipated, the EU’s top court has banned patents on embryonic stem cells as EU law prohibits patenting products that came from destroying embryos. From the France International News story: Europe’s top court on Tuesday banned researchers from patenting any process to extract stem […]

Read the full article →

Expediency Over Principle: Embryonic Stem Cell Federal Funding Lawsuit Dismissed

By Wesley J. Smith, J.D., Special Consultant to the CBC District Court Judge Royce Lamberth has dismissed the lawsuit filed against the Obama funding of ESCR. From the story: A federal judge on Wednesday dismissed a lawsuit challenging the Obama administration’s funding of stem cell research. The lawsuit, filed by Boston biological engineer James L. […]

Read the full article →

Stem Cell Fountain of Youth Story Intended to Boost CIRM Re-Up Drive?

By Wesley J. Smith, J.D., Special Consultant to the CBC As I have written here previously, the arrogantly managed and wildly expensive California Institute For Regenerative Medicine will be up for renewal in 2014. Its leaders want the suckers voters in California — already hopelessly behind the deficit 8-ball and drowning in bond debt — […]

Read the full article →

Courts Should Follow the Law Not Determine Best Policy Re Funding of Stem Cell Research

By Wesley J. Smith, J.D., Special Consultant to the CBC ESCR scientists are mounting a furious political assault against the lawsuit, currently back in Royce Lamberth’s court urging that human embryonic stem cell research continue to be funded by the Feds, hoping to pressure the judge to see it their way. From the Science Daily […]

Read the full article →

Embryonic Stem Cell Research versus the Rule of Law

By Wesley J. Smith, J.D., Special Consultant to the CBC The embryonic stem cell research controversy is an ethics, not a science, debate. But it also involves the rule of law. Indeed, two recent court rulings—one in the United States and one in Europe—illustrate how the intense politics swirling around ESCR have the potential to […]

Read the full article →

Media Bias On Stem Cell/Cloning Debates Still Biased

By Wesley J. Smith, J.D., Special Consultant to the CBC I have written about the ubiquitous media bias in the stem cell/cloning debates so often that I feel like I am trying to empty the ocean with a cup. But it is worth noting that my Discover Institute colleague, David Klinghoffer, take a good swing […]

Read the full article →

Pro ESCR Art Caplan Calls Out “Scientists” For Intentional “Over-Hype” (Lies)

By Wesley J. Smith, J.D., Special Consultant to the CBC One of the most infuriating aspects for me in the embryonic stem cell debates has been the continual hype lying I have seen — indeed, personally witnessed — by scientists. I say lying because that is a knowing and willful misstatement of fact, as opposed […]

Read the full article →

Embryonic Stem Cell Derivation Process Not Patentable, European Court Rules

By Wesley J. Smith, J.D., Special Consultant to the CBC For all the faux screaming about Bush — which was mostly pure politics — the real financial impediment to ESCR has been the patenting question. And now, the European Court of Justice has dealt a body blow to the sector. From the story: The European […]

Read the full article →

Urethras Grown From Patients’ Own Bladder Cells

By Wesley J. Smith, J.D., Special Consultant to the CBC They just keep on rolling. Scientists have used cells from patients’ own bodies to build new urethras. From the story: The boys were ages 10 to 14 at the time of the surgery. Three were accident victims, and the other two had suffered failures of […]

Read the full article →

Harvard Stem Cell Advisory Board Chair Bemoans Democratic Messiness of Science Funding

By Wesley J. Smith, J.D., Special Consultant to the CBC An reader sent along this article in the Harvard Business School Alumni Bulletin by the head of the school’s Stem Cell Advisory Board, William Sahlman, who is also a big time professor at the the Harvard Business School. He is reacting to a federal court’s […]

Read the full article →